Status of therapeutic gene transfer to treat cardiovascular disease in dogs and cats

Journal of Veterinary Cardiology

Volumn 13, Issue 2, 2011, Pages 131-140

  Sleeper, Meg ^a   Bish, Lawrence T ^b   Haskins, Mark ^a   Ponder, Katherine P ^c   Sweeney, H Lee ^b  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Gene transfer; Heart failure; Lysosomal storage disease; Mucopolysacharidosis

Indexed keywords

MYOSIN BINDING PROTEIN C;

CARDIOVASCULAR DISEASE; CAT; CELL LEVEL; CLINICAL TRIAL; DOG; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HEART FAILURE; IMMUNE COMPLEX DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME;

ANIMALS; CARDIOVASCULAR DISEASES; CAT DISEASES; CATS; DOG DISEASES; DOGS; GENE THERAPY; GENE TRANSFER TECHNIQUES;

CANIS FAMILIARIS;

EID: 79959360415     PISSN: 17602734     EISSN: 18750834     Source Type: Journal    
DOI: 10.1016/j.jvc.2011.04.001     Document Type: Review

References (59)

1. Seow Y, Wood MJ. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 2009;17:767-777.
2. Schultz BR, Chamberlain JS. Recombinant adeno-associated virus transduction and integration. Mol Ther 2008;16:1189-1199. (Pubitemid 351866049)
3. Tashiro H, Aoki M, Isobe M, Hashiya N, Makino H, Kaneda Y, Ogihara T, Morishita R. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. J Mol Cell Cardiol 2005;39:503-509. (Pubitemid 41133735)
4. Chaanine AH, Kalman J, Hajjar RJ. Cardiac gene therapy. Semin Thorac Surg 2010;22:127-139.
5. Mariani JA, Kaye DM. Delivery of gene and cellular therapies for heart disease. J Cardiovasc Trans Res 2010;3:417-426.
6. Njeim MT, Hajjar RJ. Gene therapy for heart failure. Arch Cardiovasc Dis 2010;103:477-485.
7. Roncalli J, Tongers J, Losordo DW. Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure. Arch Cardiovasc Dis 2010;103:469-476.
8. Lyon AR, Sato M, Hajjar RJ, Samulski RJ, Harding SE. Gene therapy: targeting the myocardium. Heart 2008;94:89-99.
9. Ponder KP, Melniczek JR, Xu L, Weil MA, O'Malley TM, O'Donnell PA, Knox VW, Aguirre GA, Mazrier H, Ellinwood NM, Sleeper M, Maguire AM, Volk SW, Mango RL, Zweigle J, Wolfe J, Haskins ME. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci U S A 2002;99:13102-13107.
10. Casal M, Haskins M. Large animal models and gene therapy. Eur J Hum Genet 2006;14:266-272.
11. Niemeyer GP, Herzog RW, Mount J, Arruda VR, Tillson DM, Hathcock J, van Ginkel FW, High KA, Lothrop Jr CD. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood 2009;113:797-806.
12. Margaritis P, Roy E, Aljamali MN, Downey HD, Giger U, Zhou S, Merricks E, Dillow A, Ezban M, Nichols TC, High KA. Successful treatment of canine hemophilia by continuous expression of canine FVIIa. Blood 2009;113:3682-3689.
13. Vinge LE, Raake PW, Koch WJ. Gene therapy in heart failure. Circ Res 2008;102:1458-1470.
14. Haskins M, Casal M, Ellinwood NM, Melniczek J, Mazrier H, Giger U. Animal models for mucopolysaccharidoses and their clinical relevance. Acta Paediatr Suppl 2002;91:88-97. (Pubitemid 36174158)
15. Tessitore A, Faella A, O'Malley T, Cotugno G, Doria M, Kunieda T, Matarese G, Haskins M, Auricchio A. Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle. Mol Ther 2008;16:30-37.
16. Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 2005;12:1072-1082. (Pubitemid 41723041)
17. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006;12:342-347. (Pubitemid 43355084)
18. Metcalf JA, Linders B, Wu S, Bigg P, O'Donnell P, Sleeper MM, Whyte MP, Haskins M, Ponder KP. Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression. Mol Genet Metab 2010;99:396-407.
19. Sleeper MM, Fornasari B, Ellinwood NM, Weil MA, Melniczek J, O'Malley TM, Sammarco CD, Xu L, Ponder KP, Haskins ME. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII. Circulation 2004;110:815-820. (Pubitemid 39096009)
20. Traas AM, Wang P, Ma X, Tittiger M, Schaller L, O'donnell P, Sleeper MM, Vite C, Herati R, Aguirre GD, Haskins M, Ponder KP. Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy. Mol Ther 2007;15:1423-1431.
21. Sleeper MM, Wang P, O'Donnell P, Sikora T, Levanduski L, Ponder KP, Haskins ME. Comparison of vector type and timing of gene delivery to correct cardiovascular manifestations of Mucopolysacharidosis VII. Circulation 2010:122.
22. Turecek F, Scott CR, Gelb MH. Tandem mass spectrometry in the detection of inborn errors of metabolism for newborn screening. Methods Mol Biol 2007;359:143-157. (Pubitemid 350183227)
23. Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G, Wilson JM, Sweeney HL. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 2008;19:1359-1368.
24. Bish LT, Sleeper MM, Brainard B, Cole S, Russell N, Withnall E, Arndt J, Reynolds C, Davison E, Sanmiguel J, Wu D, Gao G, Wilson JM, Lee Sweeney H. Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. Mol Ther 2008;16:1953-1959.
25. Lamping KG, Rios CD, Chun JA, Ooboshi H, Davidson BL, Heistad DD. Intrapericardial administration of adenovirus for gene transfer. Am J Physiol 1997;272:H310-H317.
26. Lazarous DF, Shou M, Stiber JA, Hodge E, Thirumurti V, Gonçalves L, Unger EF. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc Res 1999;44:294-302. (Pubitemid 29474092)
27. Laguens R, Cabeza Meckert P, Vera Janavel G, De Lorenzi A, Lascano E, Negroni J, Del Valle H, Cuniberti L, Martínez V, Dulbecco E, Melo C, Fernández N, Criscuolo M, Crottogini A. Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med 2004;6:222-227. (Pubitemid 40232984)
28. Vera Janavel G, Crottogini A, Cabeza Meckert P, Cuniberti L, Mele A, Papouchado M, Fernández N, Bercovich A, Criscuolo M, Melo C, Laguens R. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Ther 2006;13:1133-1142. (Pubitemid 44101363)
29. Ferrarini M, Arsic N, Recchia FA, Zentilin L, Zacchigna S, Xu X, Linke A, Giacca M, Hintze TH. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006;98:954-961.
30. McTiernan CF, Mathier MA, Zhu X, Xiao X, Klein E, Swan CH, Mehdi H, Gibson G, Trichel AM, Glorioso JC, Feldman AM, McCurry KR, London B. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts. Gene Ther 2007;14:1613-1622. (Pubitemid 350143187)
31. Bridges CR, Burkman JM, Malekan R, Konig SM, Chen H, Yarnall CB, Gardner TJ, Stewart AS, Stecker MM, Patterson T, Stedman HH. Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg 2002;73:1939-1946. (Pubitemid 34596745)
32. Bridges CR, Gopal K, Holt DE, Yarnall C, Cole S, Anderson RB, Yin X, Nelson A, Kozyak BW, Wang Z, Lesniewski J, Su LT, Thesier DM, Sundar H, Stedman HH. Efficient myocyte gene delivery with complete cardiac surgical isolation in situ. J Thorac Cardiovasc Surg 2005;130:1364.
33. Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 2008;15:1550-1557.
34. Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ. Calcium up-regulation by percutaneous administration of gene therapy in cardiac disease (CUPID) trial investigators. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail 2009;15:171-181.
35. Del Monte F, Hajjar RJ. Intracellular devastation in heart failure. Heart Fail Rev 2008;13:151-162.
36. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995;92:778-784.
37. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol 1997;92:87-93. (Pubitemid 27254285)
38. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J, Kranias EG, Giles WR, Chien KR. Chronic phospholamban- sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 1999:313-322. (Pubitemid 29519910)
39. Dieterle T, Meyer M, Gu Y, Belke DD, Swanson E, Iwatate M, Hollander J, Peterson KL, Ross Jr J, Dillmann WH. Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure. Cardiovasc Res 2005;67:678-688. (Pubitemid 41033363)
40. Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross Jr J, Chien KR. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 2002;8:864-871.
41. Manning BS, Shotwell K, Mao L, Rockman HA, Koch WJ. Physiological induction of a beta-adrenergic receptor kinase inhibitor transgene preserves ss-adrenergic responsiveness in pressure-overload cardiac hypertrophy. Circulation 2000;102:2751-2757.
42. Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, Gao E, Dasgupta A, Rengo G, Remppis A, Katus HA, Eckhart AD, Rabinowitz JE, Koch WJ. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 2007;115:2506-2515. (Pubitemid 46763224)
43. Most P, Pleger ST, Volkers M, Heidt B, Boerries M, Weichenhan D, Loffler E, Janssen PM, Eckhart AD, Martini J, Williams ML, Katus HA, Remppis A, Koch WJ. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest 2004;114:1550-1563. (Pubitemid 40385546)
44. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar J, Mariani JA, Pepe S, Chien KR, Power JM. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007;50:253-260. (Pubitemid 47031573)
45. 2+ cycling and new therapeutic approaches for heart failure. Circulation 2010;121:822-830.
46. Baty CJ, Malarkey DE, Atkins CE, DeFrancesco TC, Sidley J, Keene BW. Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats. J Vet Intern Med 2001;15:595-599. (Pubitemid 33722429)
47. Baty CJ. Feline hypertrophic cardiomyopathy: an update. Vet Clin North Am Small Anim Pract 2004;34:1227-1234. (Pubitemid 39172713)
48. Borgarelli M, Tarducci A, Tidholm A, Haggstrom J. Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy. Vet J 2001;162:182-195 [see comment].
49. Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008;22:120-128. (Pubitemid 351361460)
50. Serres F, Chetboul V, Tissier R, Sampedrano CC, Gouni V, Nicolle AP, Pouchelon JL. Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001-2006). J Vet Intern Med 2007;21:258-264.
51. Tidholm A, Haggstrom J, Borgarelli M, Tarducci A. Canine idiopathic dilated cardiomyopathy. Part I: aetiology, clinical characteristics, epidemiology and pathology. Vet J 2001;162:92-107.
52. Martin MW, Stafford Johnson MJ, Celona B. Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases. J Small Anim Pract 2009;50:23-29.
53. Meurs KM, Ederer MM, Stern JA. Desmosomal gene evaluation in Boxers with arrhythmogenic right ventricular cardiomyopathy. Am J Vet Res 2007;68:1338-1341. (Pubitemid 350267963)
54. Meurs KM, Norgard MM, Ederer MM, Hendrix KP, Kittleson MD. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics 2007;90:261-264. (Pubitemid 47030809)
55. Meurs KM, Sanchez X, David RM, Bowles NE, Towbin JA, Reiser PJ, Kittleson JA, Munro MJ, Dryburgh K, Macdonald KA, Kittleson MD. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 2005;14:3587-3593. (Pubitemid 41754660)
56. Kittleson MD, Meurs KM, Munro MJ, Kittleson JA, Liu SK, Pion PD, Towbin JA. Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease. Circulation 1999;99:3172-3180. (Pubitemid 29289084)
57. Dambach DM, Lannon A, Sleeper MM, Buchanan J. Familial dilated cardiomyopathy of young Portuguese water dogs. J Vet Intern Med 1999;13:65-71.
58. Sleeper MM, Henthorn PS, Vijayasarathy C, Dambach DM, Bowers T, Tijskens P, Armstrong CF, Lankford EB. Dilated cardiomyopathy in juvenile Portuguese water dogs. J Vet Intern Med 2002;16:52-62. (Pubitemid 135746923)
59. Werner P, Raducha MG, Prociuk U, Sleeper MM, Van Winkle TJ, Henthorn PS. A novel locus for dilated cardiomyopathy maps to canine chromosome 8. Genomics 2008;91:517-521.